Benefits
Weight loss support tested only in stimulant blends
In two randomized trials, overweight adults on a calorie-restricted diet and exercise program took capsules combining raspberry ketone with caffeine, capsaicin, garlic and bitter orange. One reported more weight and fat loss than placebo among the people who finished; in the other, both groups lost weight. The first was sponsored by a supplement company. With known stimulants in the mix, neither trial can credit the ketone.
Appetite and body fat changes in mice follow reduced food intake
Mice given raspberry ketone ate less and gained less weight. In a study that fed a comparison group the same reduced amount of food, the authors concluded the ketone offered limited fat-loss benefit beyond eating less. In another, doses that reliably cut intake also caused organ changes and deaths. No study has measured appetite in people taking it alone.
Lipolysis and adiponectin effects seen in fat cells
In isolated rat fat cells, raspberry ketone boosted norepinephrine-triggered fat breakdown, and in cultured mouse fat cells it raised fatty acid burning and adiponectin release. These are laboratory results. In the two human blend trials, adiponectin did not change in one and rose in the other, which says little about the ketone itself.
Raspberry aroma compound, not a raspberry extract
Raspberry ketone is a flavor molecule. Raspberries contain up to about 4.3 mg per kilogram, so a single 100 mg serving would take more than 20 kg of fruit. In the US it is listed as a synthetic flavoring substance permitted in the minimum amount needed for flavor, and that listing does not address supplement-level daily intake.
Safety at supplement doses is not established
Formal toxicity data come only from short-term rodent studies, and high doses killed mice in two of them. Danish food safety scientists calculated that the lowest labeled dose, 100 mg, is 56 times the threshold of toxicological concern for its chemical class, with a safety margin of only 12 at 1,400 mg. UK regulators have regarded the pure compound as a novel food that needs authorization.
Mechanism of action
Hormone-sensitive lipase and norepinephrine-driven lipolysis
In rat fat cells, raspberry ketone increased the fat breakdown triggered by norepinephrine and moved hormone-sensitive lipase from the cell interior onto lipid droplets, where the enzyme acts. The finding comes from isolated animal cells and has not been measured in human fat tissue.
Adiponectin and fatty acid oxidation in cultured adipocytes
At 10 micromolar in 3T3-L1 mouse fat cells, raspberry ketone increased lipolysis, fatty acid oxidation and adiponectin expression and secretion while reducing lipid accumulation. Whether oral doses in people produce tissue concentrations like these is unknown, because human pharmacokinetic data are lacking.
Reduced food intake as the main driver in animals
In mice, lower weight gain on raspberry ketone went with eating less. A 200 mg/kg oral dose cut 24-hour intake by 24% in males and 640 mg/kg cut it by 49-77%, without signs of nausea-type behavior, but that higher single dose killed 6 of 14 male mice within two days.
Structural kinship with synephrine and capsaicin
Raspberry ketone resembles synephrine and capsaicin in structure, a likeness the first rodent obesity study gave as its starting point. Clinicians reporting coronary artery spasm after a first dose raised the possibility of an adrenaline-like sympathetic effect; that link remains a hypothesis.
Clinical trials
Randomized, double-blind, placebo-controlled 8-week trial of a multi-ingredient product (Prograde Metabolism) containing raspberry ketone, caffeine, capsaicin, garlic, ginger and Citrus aurantium, sponsored by Ultimate Wellness Systems; it did not test raspberry ketone alone (Lopez et al. 2013, J Int Soc Sports Nutr)
70 obese but otherwise healthy adults on a calorie-restricted diet with exercise training; 45 completed and were analyzed (27 on the blend, 18 on placebo).
Among completers, body weight fell 2.0% on the blend versus 0.5% on placebo and fat mass 7.8% versus 2.8%, with larger waist and hip reductions. Heart rate, blood pressure and blood chemistries did not differ between groups. More than a third of participants dropped out, the capsules contained caffeine and bitter orange, and two authors reported research funding from or consulting for supplement companies including the sponsor, so the result cannot be credited to raspberry ketone.
Randomized, double-blind, placebo-controlled 8-week trial of 4 capsules a day of a supplement containing raspberry ketone, capsaicin, caffeine, garlic and Citrus aurantium, by the same research group; it did not test raspberry ketone alone (Arent et al. 2018, J Am Coll Nutr)
36 overweight men and women, 18 per group, on calorie restriction with supervised exercise three times a week.
Weight, fat mass and body fat percentage fell in both groups, and the abstract does not report a supplement advantage for those outcomes. Group differences were limited to a lean mass gain in men, a larger hip girth reduction in women, lower leptin and higher adiponectin. Any contribution from raspberry ketone cannot be separated from the stimulants in the blend.
Animal study comparing high-fat diets containing 0.25% or 1.74% raspberry ketone with a control diet and a pair-fed group; no humans were studied (Cotten et al. 2017, Food Funct)
C57BL/6 mice fed a high-fat diet for two weeks, then five weeks on the test diets.
Both doses reduced food intake and body weight compared with control. The low dose did not change liver fat compared with pair-fed mice eating the same amount, and plasma adiponectin was unchanged. The high dose, which had no matched pair-fed group, gave the lowest liver fat and less inguinal fat relative to body weight but a heavier liver. The authors concluded raspberry ketone has limited benefit for fat loss beyond reducing energy intake.
Animal study of single oral gavage doses of 64 to 640 mg/kg raspberry ketone; no humans were studied (Hao et al. 2020, Food Chem Toxicol)
Male and female C57BL/6J mice.
Cumulative 24-hour food intake fell 24% at 200 mg/kg in males and 49-77% at 640 mg/kg. A single 640 mg/kg dose killed 6 of 14 male mice within two days, with white fat atrophy, spleen abnormalities, thymus shrinkage and lower white blood cell counts. The authors concluded that doses which reliably suppress feeding are associated with pathological changes.
Randomized, placebo-controlled crossover study in which each participant took placebo, a raspberry ketone supplement or a metabolic activator blend 2 hours before testing; the abstract does not give the dose, blinding or funding (Salacinski et al. 2016, J Diet Suppl)
26 young adults (10 women and 16 men, mean age 23.7 years).
Resting metabolic rate, respiratory quotient and percent fat and carbohydrate use did not differ significantly between raspberry ketones and placebo. The authors concluded that these nonstimulant products may not increase fat utilization.